Followers | 46 |
Posts | 3734 |
Boards Moderated | 0 |
Alias Born | 09/18/2018 |
Monday, June 27, 2022 5:01:12 PM
1- every time whoever dilutes, if ballas for 50K or converters for 25K, either ballas gets 50k for UBQU (not his wallet, let's be honest, if Jimmy was that level crook the SEC would have investigated him by now. they haven't so 50K to UBQU)
so jimmy could pay the debt direct with some of that 50K if the converters are beating him to it, well 25K of debt is forgiven. either way, it's a value to UBQU's balance sheet.
2- every time we nobid, we bounce. apparently nobody is capitulating, and somebody wants to replenish the bid. that is NOT the behavior of a dead dilution pig. somebody wants to trade more dilution for cash. why?
3- worst case. worst. is jimmy sells all remaining 25B for trip 1. 2.5 million dollars. which would kick converters to the curb and leave probably 1M+ dollars in jimmy's war chest.
4- all these scenarios no matter how painful sounding....are WORKING IN the WORST BEAR MARKET SINCE 1970!.
remember when the fed was pumping money into the markets pre inflation in 2021...
and UBQU ran to 0025....
we are doing pretty good in the worst scenario in 50 years. imagine what happens when we enter the next bull market. now we've taken our pain down here and UBQU has fixed a lot of its fundamental and balance sheet problems.
lastly, I suspect in 2025 president NOT joey B will probably happily sign the legalization of MJ. it won't stop the cartels, but it will heavily hurt illegal MJ imports, so I see the new legislation congress and presidency with a pro-financial and pro-closed border agenda wanting to legalize MJ.
whether it's a true sticking catalyst or not, that WILL pump the MJ sector on that day.
Recent UBQU News
- Ubiquitech Software Corporation Retains Vitello Capital Ltd. to Aid Strategic Planning and Assess Global Acquisition Opportunities • InvestorsHub NewsWire • 10/11/2023 12:09:01 PM
- Ubiquitech Reports Convertible Debt Forgiveness in Excess of $1,000,000 • InvestorsHub NewsWire • 06/22/2023 12:44:02 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM